UNITED STATES

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

~~Washington,~~Form ~~D.C. 20549~~6-K

~~FORM~~REPORT 6OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-K16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025.

Commission File Number 001-40772

Cellebrite DI Ltd.

(Translation of registrant’s name into English)

94 Shlomo Shmelzer Road

Petah Tikva 4970602, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

EXPLANATORY NOTE

~~This~~On ~~Report~~August of15, ~~Foreign~~2025, ~~Private Issuer on Form 6-K (this “Form 6-K”) filed by~~ Cellebrite DI Ltd. (the “Registrant” or “Company”) ~~consists~~announced ofthat the Company’s: Annual General Meeting of its Shareholders (i)the ~~consolidated~~“Annual ~~financial~~General ~~statements~~Meeting”) ~~for~~will ~~the~~be ~~six~~held ~~months~~on ~~ended~~Friday, ~~June 30~~September 19, 2025, ~~which~~at ~~are~~4:00 ~~attached~~p.m. ~~hereto~~Israel astime, ~~Exhibit~~at ~~99.1~~the ~~and~~Company’s ~~are~~offices ~~incorporated~~at by94 ~~reference herein;~~Shlomo ~~and~~Shmelzer ~~(ii)~~Road, ~~operating~~Petah ~~and~~Tikva ~~financial~~4970602, ~~review~~Israel. ~~and~~In ~~prospects~~connection ~~(unaudited)~~with ~~for~~ the ~~six~~Annual ~~months~~General ~~ended June 30~~Meeting, ~~2025,~~the ~~which~~Company ~~are~~hereby ~~attached~~furnishes ~~hereto as~~the ~~Exhibit 99.2 and are incorporated by reference herein.~~following documents:

~~This~~i. ~~Form~~Notice ~~6-K,~~and ~~including~~Proxy ~~its~~Statement ~~exhibits,~~with isrespect ~~incorporated by~~to ~~reference into~~ the ~~Company’s~~Annual ~~registration~~General ~~statements~~Meeting ondescribing ~~Form~~the ~~F-3~~proposals ~~(File~~to ~~No.~~be ~~333-259826)~~voted ~~filed~~upon ~~with~~at the ~~U.S.~~meeting, ~~Securities and Exchange Commission (~~the ~~“SEC”)~~procedure onfor ~~September~~voting ~~13,~~in ~~2022~~person ~~and~~or ~~Form~~by ~~S-8~~proxy ~~(File~~at ~~Nos.~~the ~~333-260878~~meeting and ~~333-278130)~~various ~~filed~~other ~~with~~details ~~the~~related ~~SEC on~~to ~~November~~the 8,meeting; ~~2021~~ and ~~March 21, 2024, respectively.~~

ii.	A Proxy Card whereby holders of Company’s shares may vote at the meeting without attending in person.

This Report on Form 6-K, and the exhibits hereto, excluding the letter from the Company’s Chief Executive Officer, are incorporated by reference into the Registrant’s registration statements on Form S-8 (File Nos. 333-260878 and 333-278130) filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 8, 2021 and March 21, 2024, respectively, and Form F-3 (File No. 333-259826) filed with the SEC on September 13, 2022.

~~EXHIBIT~~Exhibit ~~INDEX~~Index

Exhibit No.		Exhibit
Exhibit		Description
99.1		~~Consolidated~~Notice ~~financial~~and ~~statements~~Proxy ofStatement ~~Cellebrite~~for DIthe ~~Ltd.~~Company’s ~~and~~Annual ~~its~~General ~~subsidiaries~~Meeting ~~for~~of ~~the~~Shareholders ~~six-months~~to ~~ended~~be ~~June~~held 30on September 19, 2025.
99.2		~~Operating~~Proxy ~~and~~Card ~~Financial~~for ~~Review~~the ~~and~~Company’s ~~Prospects~~Annual ~~for~~General ~~the~~Meeting ~~six~~of ~~months~~Shareholders ~~ended~~to ~~June~~be 30held on September 19, 2025.
101.INS		Inline XBRL Instance Document.
101.SCH		Inline XBRL Taxonomy Extension Schema Document.
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the ~~registrant~~Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Cellebrite DI Ltd.
August 14, 2025	By:	/s/ David Barter
August 15, 2025	By:	/s/ Ayala Berler Shapira
		David Barter
		Ayala Berler Shapira, Adv.
		Chief Financial Officer
		General Counsel

Filing Compare · Cellebrite DI Ltd.